Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRSP | AZN | AMGN | GILD | BMY |
| Company | Crispr Therapeutics Ag | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 58.01 | 200.00 | 377.97 | 148.13 | 61.57 |
| High | 59.37 | 201.99 | 381.74 | 148.84 | 61.95 |
| Low | 56.41 | 197.10 | 372.71 | 145.52 | 60.43 |
| Latest | 58.07 | 201.27 | 377.42 | 147.93 | 61.34 |
| Change | -2.70 | -2.46 | -8.28 | -2.10 | -1.00 |
| % Change | -4.44% | -1.21% | -2.15% | -1.40% | -1.60% |
| Volume | 1,187,616 | 1,662,909 | 1,988,354 | 3,881,955 | 7,282,818 |
| 20-Day Average Volume | 1,640,710 | 2,425,685 | 3,035,856 | 7,716,793 | 13,918,142 |
| Previous Close | 60.77 | 203.73 | 385.70 | 150.03 | 62.34 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 53.39 | 200.72 | 374.10 | 149.97 | 60.51 |
| 20-Day Raw Stochastic | 81.15% | 62.14% | 77.54% | 43.05% | 86.53% |
| 20-Day Relative Strength | 55.96 | 55.73 | 59.90 | 57.62 | 64.89 |
| Weighted Alpha | +29.82 | +38.15 | +27.44 | +36.61 | +16.33 |
| Today's Opinion | 8% Buy | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 8% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 32% Sell | 88% Buy | 100% Buy | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.40% since 02/24/26 | -2.38% since 02/24/26 | -0.89% since 02/24/26 | +0.65% since 02/24/26 | +0.47% since 02/24/26 |
| Low | 53.75 on 02/26/26 | 197.15 on 03/03/26 | 372.71 on 03/03/26 | 143.09 on 02/26/26 | 60.47 on 03/03/26 |
| High | 61.76 on 02/26/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 1-Month | |||||
| %Chg | +12.88% since 02/03/26 | +9.43% since 02/03/26 | +12.07% since 02/03/26 | +3.71% since 02/03/26 | +10.54% since 02/03/26 |
| Low | 45.53 on 02/05/26 | 186.32 on 02/04/26 | 342.38 on 02/04/26 | 143.09 on 02/26/26 | 56.43 on 02/04/26 |
| High | 61.76 on 02/26/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +4.84% since 12/03/25 | +11.01% since 12/03/25 | +9.85% since 12/03/25 | +18.88% since 12/03/25 | +21.45% since 12/03/25 |
| Low | 45.53 on 02/05/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.22 on 12/04/25 |
| High | 61.76 on 02/26/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +10.80% since 09/03/25 | +22.82% since 09/03/25 | +33.68% since 09/03/25 | +31.52% since 09/03/25 | +30.29% since 09/03/25 |
| Low | 45.53 on 02/05/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 78.48 on 10/08/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,833,009 | 315,966,464 | 207,918,544 | 186,250,400 | 126,953,792 |
| Shares Outstanding, K | 95,985 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 3,510,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -581,600,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 860,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -130,610,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.71 | 0.32 | 0.45 | 0.36 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.37 on 02/12/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/05/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.73 | 17.76 | 18.28 | 10.14 |